Nursing and midwifery practice for maintenance of vascular access device patency. A cross-sectional survey

International Journal of Nursing Studies

Volumn 52, Issue 11, 2015, Pages 1678-1685

  Keogh, Samantha ^a,b,c   Flynn, Julie ^a,b,c   Marsh, Nicole ^a,b,c   Higgins, Niall ^a,b,c   Davies, Karen ^c   Rickard, Claire M ^a,b,c  

^a Alliance for Vascular Access Teaching and Research (AVATAR)   (Australia)

^b GRIFFITH UNIVERSITY   (Australia)

^c ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

Flushing; Midwifery practice; Nursing practice; Patency; Survey; Vascular access device

Indexed keywords

ADULT; CATHETERIZATION; CROSS-SECTIONAL STUDY; HUMAN; MIDWIFE; NURSING; QUEENSLAND; QUESTIONNAIRE; VASCULAR ACCESS DEVICE;

ADULT; CATHETERIZATION, PERIPHERAL; CROSS-SECTIONAL STUDIES; HUMANS; MIDWIFERY; QUEENSLAND; SURVEYS AND QUESTIONNAIRES; VASCULAR ACCESS DEVICES;

EID: 84942200143     PISSN: 00207489     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijnurstu.2015.07.001     Document Type: Article

References (46)

1. Abdelkefi A., Torjman L., Ladeb S., Othman T.B., Achour W., Lakhal A., Hsairi M., Kammoun L., Hassen A.B., Abdeladhim A.B. Randomized trial of prevention of catheter-related bloodstream infection by continuous infusion of low-dose unfractionated heparin in patients with hematologic and oncologic disease. J. Clin. Oncol. 2005, 23(31):7864-7870.
2. Australian Bureau of Statistics Staphylococcus aureus Bacteraemia in Australian Public Hospitals 2013, Australian Institute of Health and Welfare, Canberra.
3. Baskin J.L., Pui C.H., Reiss U., Wilimas J.A., Metzger M.L., Ribeiro R.C., Howard S.C. Management of occlusion and thrombosis associated with long-term indwelling central venous catheters. Lancet 2009, 374(9684):159-169.
4. Bausone-Gazda D., Lefaiver C.A., Walters S.A. A randomized controlled trial to compare the complications of 2 peripheral intravenous catheter-stabilization systems. J. Infus. Nurs. 2010, 33(6):371-384.
5. Bertoglio S., Rezzo R., Merlo F.D., et al. Pre-filled normal saline syringes to reduce totally implantable venous access device-associated bloodstream infection: a single institution pilot study. J. Hosp. Infect. 2013, 84(1):85-88.
6. Birch P., Ogden S., Hewson M. A randomised, controlled trial of heparin in total parenteral nutrition to prevent sepsis associated with neonatal long lines: the Heparin in Long Line Total Parenteral Nutrition (HILLTOP) trial. Arch. Dis. Child. Fetal Neonatal Ed. 2010, 95(4):F252-F257.
7. Bolton D. Improving peripheral cannulation practice at an NHS Trust. Br. J. Nurs. 2010, 19(21):1346. 1348-1350.
8. Bregenzer T., Conen D., Sakmann P., Widmer A.F. Is routine replacement of peripheral intravenous catheters necessary?. Arch. Intern. Med. 1998, 158(2):151-156.
9. Campbell S.G., Trojanowski J., Ackroyd-Stolarz S.A. How often should peripheral intravenous catheters in ambulatory patients be flushed?. J. Infus. Nurs. 2005, 28(6):399-404.
10. Chee S., Tan W. Reducing infusion phlebitis in Singapore hospitals using extended life end-line filters. J. Infus. Nurs. 2002, 25(2):95-104.
11. Chico-Padron R.M., Carrion-Garcia L., Delle-Vedove-Rosales L., Gonzalez-Vargas C.S., Marrero-Perera M., Medina-Chico S., Rodríguez-Díaz M.P., Alonso-Díaz M., Jimenez-Sosa A. Comparative safety and costs of transparent versus gauze wound dressings in intravenous catheterization. J. Nurs. Care Qual. 2011, 26(4):371-376.
12. Climo M., Diekema D., Warren D.K., Herwaldt L.A., Perl T.M., Peterson L., Plaskett T., Price C., Sepkowitz K., Solomon S., Tokars J., Fraser V.J., Wong E. Prevalence of the use of central venous access devices within and outside of the intensive care unit: results of a survey among hospitals in the prevention epicenter program of the Centers for Disease Control and Prevention. Infect. Control Hosp. Epidemiol. 2003, 24(12):942-945.
13. Cornely O.A., Bethe U., Pauls R., Waldschmidt D. Peripheral Teflon catheters: factors determining incidence of phlebitis and duration of cannulation. Infect. Control Hosp. Epidemiol. 2002, 23(5):249-253.
14. da Silva G.A., Priebe S., Dias F.N. Benefits of establishing an intravenous team and the standardization of peripheral intravenous catheters. J. Infus. Nurs. 2010, 33(3):156-160.
15. Fernandez R.S., Griffiths R.D., Murie P. Peripheral venous catheters: a review of current practices. J. Infus. Nurs. 2003, 26(6):388-392.
16. Flint A., McIntosh D., Davies M.W. Continuous infusion versus intermittent flushing to prevent loss of function of peripheral intravenous catheters used for drug administration in newborn infants. Cochrane Database Syst. Rev. 2005, (4):CD004593.
17. Goode C.J., Titler M., Rakel B., Ones D.S., Kleiber C., Small S., Triolo P.K. A meta-analysis of effects of heparin flush and saline flush: quality and cost implications. Nurs. Res. 1991, 40(6):324-330.
18. Hadaway L. Technology of flushing vascular access devices. J. Infus. Nurs. 2006, 29(3):129-145.
19. Homer L.D., Holmes K.R. Risks associated with 72- and 96-hour peripheral intravenous catheter dwell times. J. Intraven. Nurs. 1998, 21(5):301-305.
20. Infusion Nurses Society Infusion Nursing Standards of Practice. J. Infus. Nurs. 2011, 34:S59.
21. Macklin D. What's physics got to do with it?. J. Vasc. Access Dev. 1999, 4(2):7-13.
22. Maki D.G., Kluger D.M., Crnich C.J. The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. Mayo Clin. Proc. 2006, 81(9):1159-1171.
23. Maki D.G., Ringer M. Risk factors for infusion-related phlebitis with small peripheral venous catheters. A randomized controlled trial. Ann. Intern. Med. 1991, 114(10):845-854.
24. Mermel L.A., Allon M., Bouza E., Craven D.E., Flynn P., O'Grady N.P., Raad I.I., Rijnders B.J., Sherertz R.J., Warren D.K. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin. Infect. Dis. 2009, 49(1):1-45.
25. Perucca R. Peripheral venous access devices. Infusion Nursing: An Evidence-Based Approach 2010, 456-479. Saunders/Elsevier, St Louis, MO. M. Alexander, A. Corrigan, L. Gorski, J. Hankins, R. Perucca (Eds.).
26. Peterson F.Y., Kirchhoff K.T. Analysis of the research about heparinized versus nonheparinized intravascular lines. Heart Lung 1991, 20(6):631-640.
27. Pierce C.M., Wade A., Mok Q. Heparin-bonded central venous lines reduce thrombotic and infective complications in critically ill children. Intensive Care Med. 2000, 26(7):967-972.
28. Queensland Health Insertion and Management of Central Venous Catheters Guidelines 2011, Queensland Government, Brisbane, Australia.
29. Raad I., Chatzinikolaou I., Chaiban G., Hanna H., Hachem R., Dvorak T., Cook G., Costerton W. In vitro and ex vivo activities of minocycline and EDTA against microorganisms embedded in biofilm on catheter surfaces. Antimicrob. Agents Chemother. 2003, 47(11):3580-3585.
30. Raad I., Hachem R., Tcholakian R.K., Sherertz R. Efficacy of minocycline and EDTA lock solution in preventing catheter-related bacteremia, septic phlebitis, and endocarditis in rabbits. Antimicrob. Agents Chemother. 2002, 46(2):327-332.
31. Raad I., Hanna H., Maki D. Intravascular catheter-related infections: advances in diagnosis, prevention, and management. Lancet Infect. Dis. 2007, 7(10):645-657.
32. Randolph A.G., Cook D.J., Gonzales C.A., Andrew M. Benefit of heparin in peripheral venous and arterial catheters: systematic review and meta-analysis of randomised controlled trials. BMJ 1998, 316(7136):969-975.
33. Registered Nurses' Association of Ontario Care and Maintenance to Reduce Vascular Access Complications 2005, RNAO, Toronto, Canada.
34. Rickard C.M., McCann D., Munnings J., McGrail M.R. Routine resite of peripheral intravenous devices every 3 days did not reduce complications compared with clinically indicated resite: a randomised controlled trial. BMC Med. 2010, 8:53.
35. Rickard C.M., Webster J., Wallis M.C., Marsh N., McGrail M.R., French V., Foster L., Gallagher P., Gowardman J.R., Zhang L., McClymont A., Whitby M. Routine versus clinically indicated replacement of peripheral intravenous catheters: a randomised controlled equivalence trial. Lancet 2012, 380(9847):1066-1074.
36. Roberts G.W., Holmes M.D., Staugas R.E., Day R.A., Finlay C.F., Pitcher A. Peripheral intravenous line survival and phlebitis prevention in patients receiving intravenous antibiotics: heparin/hydrocortisone versus in-line filters. Ann. Pharmacother. 1994, 28(1):11-16.
37. Royer T. Improving short peripheral IV outcomes: a clinical trial of two securement methods. J. Assoc. Vasc. Access 2003, 8(4):45-49.
38. Schreiber S., Zanchi C., Ronfani L., et al. Normal saline flushes performed once daily maintain peripheral intravenous catheter patency: a randomised controlled trial. Arch. Dis. Child. 2015, 100(7):700-703.
39. Shah C.B., Mittelman M.W., Costerton J.W., Parenteau S., Pelak M., Arsenault R., Mermel L.A. Antimicrobial activity of a novel catheter lock solution. Antimicrob. Agents Chemother. 2002, 46(6):1674-1679.
40. Shanks R.M., Donegan N.P., Graber M.L., Buckingham S.E., Zegans M.E., Cheung A.L., O'Toole G.A. Heparin stimulates Staphylococcus aureus biofilm formation. Infect. Immun. 2005, 73(8):4596-4606.
41. Sona C., Prentice D., Schallom L. National survey of central venous catheter flushing in the intensive care unit. Crit. Care Nurse 2012, 32(1):e12-e19.
42. Timsit J.F., Dubois Y., Minet C., Bonadona A., Lugosi M., Ara-Somohano C., Hamidfar-Roy R., Schwebel C. New challenges in the diagnosis, management, and prevention of central venous catheter-related infections. Semin. Respir. Crit. Care Med. 2011, 32(2):139-150.
43. Timsit J.F., Dubois Y., Minet C., Bonadona A., Lugosi M., Ara-Somohano C., Hamidfar-Roy R., Schwebel C. New materials and devices for preventing catheter-related infections. Ann. Intensive Care 2011, 1:34.
44. Tuffaha H.W., Rickard C.M., Webster J., Marsh N., Gordon L., Wallis M., Scuffham P.A. Cost-effectiveness analysis of clinically indicated versus routine replacement of peripheral intravenous catheters. Appl. Health Econ. Health Policy 2014, 12(1):51-58.
45. Wenzel R.P., Edmond M.B. Team-based prevention of catheter-related infections. N. Engl. J. Med. 2006, 355(26):2781-2783.
46. White S.A. Peripheral intravenous therapy-related phlebitis rates in an adult population. J. Intraven. Nurs. 2001, 24(1):19-24.